Exelixis Inc. (EXEL)
Exelixis Statistics
Share Statistics
Exelixis has 279.88M shares outstanding. The number of shares has increased by -3.92% in one year.
Shares Outstanding | 279.88M |
Shares Change (YoY) | -3.92% |
Shares Change (QoQ) | -2% |
Owned by Institutions (%) | 86.33% |
Shares Floating | 271.82M |
Failed to Deliver (FTD) Shares | 2.77K |
FTD / Avg. Volume | 0.1% |
Short Selling Information
The latest short interest is 14.46M, so 5.06% of the outstanding shares have been sold short.
Short Interest | 14.46M |
Short % of Shares Out | 5.06% |
Short % of Float | 5.2% |
Short Ratio (days to cover) | 5.82 |
Valuation Ratios
The PE ratio is 18.9 and the forward PE ratio is 15.12. Exelixis's PEG ratio is 0.11.
PE Ratio | 18.9 |
Forward PE | 15.12 |
PS Ratio | 4.54 |
Forward PS | 2.8 |
PB Ratio | 4.39 |
P/FCF Ratio | 14.08 |
PEG Ratio | 0.11 |
Enterprise Valuation
Exelixis Inc. has an Enterprise Value (EV) of 7.56B.
EV / Earnings | 14.5 |
EV / Sales | 3.49 |
EV / EBITDA | 10.52 |
EV / EBIT | 12.5 |
EV / FCF | 10.8 |
Financial Position
The company has a current ratio of 3.63, with a Debt / Equity ratio of 0.09.
Current Ratio | 3.63 |
Quick Ratio | 3.58 |
Debt / Equity | 0.09 |
Total Debt / Capitalization | 7.84 |
Cash Flow / Debt | 3.67 |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.23% and return on capital (ROIC) is 18.99%.
Return on Equity (ROE) | 0.23% |
Return on Assets (ROA) | 0.18% |
Return on Capital (ROIC) | 18.99% |
Revenue Per Employee | $1,890,759.37 |
Profits Per Employee | $454,461.2 |
Employee Count | 1,147 |
Asset Turnover | 0.74 |
Inventory Turnover | n/a |
Taxes
Income Tax | 160.37M |
Effective Tax Rate | 0.24 |
Stock Price Statistics
The stock price has increased by 55.95% in the last 52 weeks. The beta is 0.57, so Exelixis's price volatility has been higher than the market average.
Beta | 0.57 |
52-Week Price Change | 55.95% |
50-Day Moving Average | 35.75 |
200-Day Moving Average | 30.35 |
Relative Strength Index (RSI) | 50.71 |
Average Volume (20 Days) | 2.71M |
Income Statement
In the last 12 months, Exelixis had revenue of 2.17B and earned 521.27M in profits. Earnings per share was 1.8.
Revenue | 2.17B |
Gross Profit | 2.17B |
Operating Income | 604.62M |
Net Income | 521.27M |
EBITDA | 718.75M |
EBIT | 604.62M |
Earnings Per Share (EPS) | 1.8 |
Balance Sheet
The company has 217.37M in cash and 190.82M in debt, giving a net cash position of 26.55M.
Cash & Cash Equivalents | 217.37M |
Total Debt | 190.82M |
Net Cash | 26.55M |
Retained Earnings | -98.65M |
Total Assets | 2.95B |
Working Capital | 1.06B |
Cash Flow
In the last 12 months, operating cash flow was 699.97M and capital expenditures 0, giving a free cash flow of 699.97M.
Operating Cash Flow | 699.97M |
Capital Expenditures | 0 |
Free Cash Flow | 699.97M |
FCF Per Share | 2.41 |
Margins
Gross margin is 100%, with operating and profit margins of 27.88% and 24.04%.
Gross Margin | 100% |
Operating Margin | 27.88% |
Pretax Margin | 31.43% |
Profit Margin | 24.04% |
EBITDA Margin | 33.14% |
EBIT Margin | 27.88% |
FCF Margin | 32.28% |
Dividends & Yields
EXEL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 4.87% |
FCF Yield | 6.77% |
Analyst Forecast
The average price target for EXEL is $39, which is 5.6% higher than the current price. The consensus rating is "Buy".
Price Target | $39 |
Price Target Difference | 5.6% |
Analyst Consensus | Buy |
Analyst Count | 18 |
Scores
Altman Z-Score | 10.69 |
Piotroski F-Score | 8 |